Publikationen 2023

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
BJUI Compass 2023; 4(1): 123-129;
Bravi CA, Heidenreich A, Fossati N, Gandaglia G, Suardi N, Mazzone E, Stabile A, Cucchiara V, Osmonov D, Juenemann KP, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat S, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A, Pfister D

Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance-A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting.
Bioengineering (Basel) 2023; 10(2)
Ebner B, Apfelbeck M, Pyrgidis N, Nellessen T, Ledderose S, Pfitzinger PL, Volz Y, Berg E, Enzinger B, Rodler S, Atzler M, Ivanova T, Clevert DA, Stief CG, Chaloupka M

Interstitial Photodynamic Therapy of Glioblastomas: A Long-Term Follow-up Analysis of Survival and Volumetric MRI Data.
Cancers. 2023; 15(9)
Foglar M, Aumiller M, Bochmann K, Buchner A, El Fahim M, Quach S, Sroka R, Stepp H, Thon N, Forbrig R, Rühm A.

P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.
Cancers (Basel) 2023; 15(8)
Ledderose S, Rodler S, Eismann L, Ledderose G, Rudelius M, Junger WG, Ledderose C

Radical Prostatectomy without Prior Biopsy in Patients with High Suspicion of Prostate Cancer Based on Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography: A Prospective Cohort Study.
Cancers (Basel) 2023; 15(4)
Chaloupka M, Apfelbeck M, Pyrgidis N, Marcon J, Weinhold P, Stief CG

Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis.
Cancers (Basel) 2023; 15(4)
Petov V, Azilgareeva C, Shpikina A, Morozov A, Krupinov G, Kozlov V, Singla N, Gómez Rivas J, Jesús MS, Puliatti S, Checcucci E, Rodler S, Belenchon IR, Kowalewski KF, Veccia A, Mcfarland J, Cacciamani GE, Taratkin M, Enikeev D

DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score.
Clin Transl Radiat Oncol 2023; 39
Unger K, Hess J, Link V, Buchner A, Eze C, Li M, Stief C, Kirchner T, Klauschen F, Zitzelsberger H, Niyazi M, Ganswindt U, Schmidt-Hegemann N-S, Belka C

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy.
Clin Transl Radiat Oncol 2023; 39
Li M, Fan Y, Trapp C, Schmidt-Hegemann NS, Ma J, Buchner A, Lu S, Xu B, Stief C, Wang X, Zhou C, Belka C, Rogowski P

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Eur J Nucl Med Mol Imaging 2023;
Spohn SKB, Schmidt-Hegemann NS, Ruf J, Mix M, Benndorf M, Bamberg F, Makowski MR, Kirste S, Rühle A, Nouvel J, Sprave T, Vogel MME, Galitsnaya P, Gschwend JE, Gratzke C, Stief C, Löck S, Zwanenburg A, Trapp C, Bernhardt D, Nekolla SG, Li M, Belka C, Combs SE, Eiber M, Unterrainer L, Unterrainer M, Bartenstein P, Grosu AL, Zamboglou C, Peeken JC

Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
Eur Urol Focus 2023;
Schallenberg S, Dragomir MP, Anders P, Ebner B, Volz Y, Eismann L, Rodler S, Casuscelli J, Buchner A, Klauschen F, Stief C, Horst D, Schulz GB

Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Eur Urol Focus 2023;
Zattoni F, Marra G, Martini A, Kasivisvanathan V, Grummet J, Harkin T, Ploussard G, Olivier J, Chiu PK, Valerio M, Marquis A, Gontero P, Guo H, Zhuang J, Frydenberg M, Moon D, Morlacco A, Kretschmer A, Barletta F, Heidegger I, Tilki D, van den Bergh R, Dal Moro F, Briganti A, Montorsi F, Novara G, Gandaglia G, EAU-YAU Prostate Cancer Working Party

Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
Eur Urol Focus 2023; 9(1): 145-153
Gresser E, Woznicki P, Messmer K, Schreier A, Kunz WG, Ingrisch M, Stief C, Ricke J, Nörenberg D, Buchner A, Schulz GB

Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort.
Eur Urol Focus 2023;
Calleris G, Marra G, Benfant N, Rajwa P, Ahmed M, Abreu A, Cacciamani G, Ghoreifi A, Ribeiro L, Westhofen T, Tourinho-Barbosa R, Raskin Y, Veerman H, Albisinni S, Smith JA, Rouprêt M, Oderda M, Massari E, Persad R, Van Der Poel H, Joniau S, Sanchez-Salas R, Kretschmer A, Cathcart P, Gill I, Karnes RJ, Tilki D, Shariat SF, Touijer K, Gontero P

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
Front Med (Lausanne) 2023; 9
Sauerbruch T, Hennenberg M, Trebicka J, Schierwagen R

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003.
Front Pharmacol 2023; 14
Liu Y, Wang R, Huang R, Rutz B, Ciotkowska A, Tamalunas A, Hu S, Trieb M, Waidelich R, Strittmatter F, Stief CG, Hennenberg M

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.
J Cancer Res Clin Oncol 2023; 149(5): 1905-1915;
Heinrich K, Miller-Phillips L, Ziemann F, Hasselmann K, Rühlmann K, Flach M, Biro D, von Bergwelt-Baildon M, Holch J, Herold T, von Baumgarten L, Greif PA, Jeremias I, Wuerstlein R, Casuscelli J, Spitzweg C, Seidensticker M, Renz B, Corradini S, Baumeister P, Goni E, Tufman A, Jung A, Kumbrink J, Kirchner T, Klauschen F, Metzeler KH, Heinemann V, Westphalen CB

Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
J Natl Compr Canc Netw 2023; 21(1): 43-50.e2;
Mehrens D, Kramer KKM, Unterrainer LM, Beyer L, Bartenstein P, Froelich MF, Tollens F, Ricke J, Rübenthaler J, Schmidt-Hegemann NS, Herlemann A, Unterrainer M, Kunz WG

Interstitial photodynamic therapy for newly diagnosed glioblastoma.
J Neurooncol 2023; 162(1): 217-223;
Quach S, Schwartz C, Aumiller M, Foglar M, Schmutzer M, Katzendobler S, El Fahim M, Forbrig R, Bochmann K, Egensperger R, Sroka R, Stepp H, Rühm A, Thon N

An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients.
J Nucl Med 2023;
Trapp C, Oliinyk D, Rogowski P, Von Bestenbostel R, Ganswindt U, Li M, Eze C, Bartenstein P, Beyer L, Ilhan H, Sheikh G, Unterrainer L, Stief C, Westhofen T, Kunz WG, Unterrainer M, Belka C, Schmidt-Hegemann NS

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy.
J Urol 2023;
Reese SW, Khaleel S, Silagy A, Xie A, Eismann L, Vazquez-Rivera K, Oparanozie A, Patil S, Coleman J, Motzer R, Kotecha RR, Russo P, Voss MH, Hakimi AA

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet 2023; 401(10379): 821-832; 
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol 2023; 24(3): 228-238;
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG

[Early detection of prostate cancer].
MMW Fortschr Med 2023; 165(8): 50-52;
Rodler S, Stief CG

[Urinary tract infections in children].
MMW Fortschr Med 2023; 165(7): 58-59;
Stredele R, Atzler M, Becker KM, Zeller C, Lisec K, Kammer B, Stief CG, Heinrich MB

Quantitative differentiation of minimal-fat angiomyolipomas from renal cell carcinomas using grating-based x-ray phase-contrast computed tomography: An ex vivo study.
PLoS ONE 2023; 18(4)
Birnbacher L, Braunagel M, Willner M, Marschner M, De Marco F, Viermetz M, Auweter S, Notohamiprodjo S, Hellbach K, Notohamiprodjo M, Staehler M, Pfeiffer D, Reiser MF, Pfeiffer F, Herzen J

A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.
Prostate Cancer Prostatic Dis 2023; 
Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D, Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology

Enucleation of the prostate as retreatment for recurrent or residual benign prostatic obstruction: a systematic review and a meta-analysis.
Prostate Cancer Prostatic Dis 2023;
Pyrgidis N, Mykoniatis I, Lusuardi L, Schulz GB, Sokolakis I, Stief C, Sountoulides P

Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Radiother Oncol 2023;
Scharl S, Zamboglou C, Strouthos I, Farolfi A, Serani F, Lanzafame H, Giuseppe Morganti A, Trapp C, Koerber SA, Debus J, Peeken JC, Vogel MME, Vrachimis A, K B Spohn S, Ruf J, Grosu AL, Ceci F, Fendler WP, Bartenstein P, Kroeze SGC, Guckenberger M, Krafcsik M, Klopscheck C, Fanti S, Hruby G, Emmett L, Belka C, Stief C, Schmidt-Hegemann NS, Henkenberens C, Mayer B, Miksch J, Shelan M, Aebersold DM, Thamm R, Wiegel T

Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial.
Strahlenther Onkol 2023;
Krug D, Imhoff D, Haidenberger A, Heßler N, Schäfer J, Huttenlocher S, Chatzikonstantinou G, Fürweger C, Ramm U, König IR, Chun F, Staehler M, Rödel C, Muacevic A, Vonthein R, Dunst J, Blanck O

[Benign Prostate Hyperplasia - Current Medical Therapy, New Developments, and Side Effects].
Ther Umsch 2023; 80(3): 113-122;
Tamalunas A, Keller P, Schott M, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G

[Laser Techniques in the Treatment of Benign Prostatic Syndrome].
Ther Umsch 2023; 80(3): 141-146;
Brinkmann I, Schott M, Keller P, Tamalunas A, Atzler M, Ebner B, Stief CG, Magistro G

Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
Urol Int 2023; 107(1): 72-79;
Eismann L, Bohn L, Buchner A, Casuscelli J, Volz Y, Weinhold P, Wülfing C, Waidelich R, Stief CG, Schlenker B, Rodler S

Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence.
Urol Oncol 2023;
Eismann L, von Walter P, Jung A, Chaloupka M, Rodler S, Westhofen T, Buchner A, Stief CG, Stadler T, Schlenker B

[Common errors, pitfalls, and management of complications of prostate biopsy : The most common diagnostic and procedural challenges of transrectal fusion prostate biopsy in the initial diagnosis of clinically significant prostate cancer].
Urologie 2023;
Enzinger B, Pfitzinger PL, Ebner B, Ivanova T, Volz Y, Apfelbeck M, Kazmierczak P, Stief C, Chaloupka M

[Current state of prostate biopsy].
Urologie 2023; 62(5): 447-448;
Stief CG

[Transrectal vs. transperineal fusion biopsy of the prostate : Time to switch to the perineal technique-comparison of methods and description of the transperineal procedure under local anesthesia].
Urologie 2023;
Pfitzinger PL, Enzinger B, Ebner B, Ivanova T, Volz Y, Chaloupka M, Apfelbeck M, Stief C

Efficacy, Efficiency, and Safety of En-bloc vs. Three-lobe Enucleation of the Prostate: A Propensity Score-Matched Analysis.
Urology 2023;
Tamalunas A, Schott M, Keller P, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G

Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.
World J Mens Health 2023; 
Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW

Assessment of single-probe dual-energy lithotripters in percutaneous nephrolithotomy: a systematic review and meta-analysis of preclinical and clinical studies.
World J Urol 2023;
Mykoniatis I, Pyrgidis N, Tzelves L, Pietropaolo A, Juliebø-Jones P, De Coninck V, Hameed BMZ, Chaloupka M, Schulz GB, Stief C, Kallidonis P, Somani BK, Skolarikos A